High dose samarium-153 EDTMP (ethylenediaminetetramethylene phosphonic acid) and Melphalan chemotherapy with peripheral blood stem cell rescue for therapy of patients with multiple myeloma: Phase I and II clinical trial preliminary results.

被引：0
|
作者：
Wiseman, GA [1 ]
Dispensieri, A [1 ]
Lacy, MQ [1 ]
Gertz, MA [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
569
引用
收藏
页码：174P / 175P
页数：2
相关论文
共 50 条
  • [1] Phase I high dose 153samarium ethylenediaminetetramethylenephosphonate (153-Sm EDTMP) and melphalan therapy of multiple myeloma (MM) with peripheral blood stem cell (PBSC) support.
    Wiseman, GA
    Dispenzieri, A
    Anderson, PM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 155P - 155P
  • [2] A phase II study of high dose 153-samarium EDTMP (153-sm EDMTP) and melphalan for peripheral stem cell transplantation (PBSCT) in multiple myeloma (MM)
    Dispenzieri, A
    Wiseman, GA
    Lacy, MQ
    Geyer, S
    Litzow, MR
    Tefferi, A
    Inwards, DJ
    Micallef, IN
    Ansell, S
    Gastineau, DA
    Porrata, L
    Elliott, MA
    Gertz, MA
    BLOOD, 2003, 102 (11) : 982A - 982A
  • [3] A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
    Dispenzieri, Angela
    Wiseman, Gregory A.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Buadi, Francis
    Dingli, David
    Laumann, Krista M.
    Allred, Jake
    Geyer, Susan M.
    Litzow, Mark R.
    Gastineau, Dennis A.
    Inwards, David J.
    Micallef, Ivana N.
    Ansell, Stephen M.
    Porrata, Luis
    Elliott, Michelle A.
    Johnston, Patrick B.
    Hogan, William J.
    Gertz, Morie A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (06) : 409 - 413
  • [4] A phase I/II dose escalation study of 153-Samarium EDTMP (153-Sm-EDMTP) with fixed dose melphalan peripheral stem cell transplantation (PBSCT) for multiple myeloma (MM).
    Dispenzieri, A
    Wiseman, G
    Lacy, MQ
    Litzow, MR
    Tefferi, A
    Inwards, DJ
    Micallef, IN
    Gastineau, DA
    Ansell, S
    Rajkumar, SV
    Fonseca, R
    Porrata, L
    Witzig, TE
    Lust, JA
    Kyle, RA
    Greipp, PR
    Gertz, MA
    BLOOD, 2001, 98 (11) : 682A - 683A
  • [5] A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
    A Dispenzieri
    G A Wiseman
    M Q Lacy
    M R Litzow
    P M Anderson
    D A Gastineau
    A Tefferi
    D J Inwards
    I N M Micallef
    S M Ansell
    L Porrata
    M A Elliott
    J A Lust
    P R Greipp
    S V Rajkumar
    R Fonseca
    T E Witzig
    C Erlichman
    J A Sloan
    M A Gertz
    Leukemia, 2005, 19 : 118 - 125
  • [6] A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
    Dispenzieri, A
    Wiseman, GA
    Lacy, MQ
    Litzow, MR
    Anderson, PM
    Gastineau, DA
    Tefferi, A
    Inwards, DJ
    Micallef, INM
    Ansell, SM
    Porrata, L
    Elliott, MA
    Lust, JA
    Greipp, PR
    Rajkumar, SV
    Fonseca, R
    Witzig, TE
    Erlichman, C
    Sloan, JA
    Gertz, MA
    LEUKEMIA, 2005, 19 (01) : 118 - 125
  • [7] Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma
    CH Weaver
    B Zhen
    LS Schwartzberg
    R Leff
    M Magee
    L Geier
    K Deaton
    L Lewkow
    CD Buckner
    Bone Marrow Transplantation, 1998, 22 : 245 - 251
  • [8] Phase I-II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma
    Weaver, CH
    Zhen, B
    Schwartzberg, LS
    Leff, R
    Magee, M
    Geier, L
    Deaton, K
    Lewkow, L
    Buckner, CD
    BONE MARROW TRANSPLANTATION, 1998, 22 (03) : 245 - 251
  • [9] Phase I trial of sequential high dose chemotherapy with GCSF primed peripheral blood stem cell rescue in patients with advanced cancer
    Weckstein, D
    Sprague, K
    Hurley, C
    Karp, D
    Berkman, E
    Curtin, P
    Schenkein, D
    Sweet, M
    Miller, K
    BLOOD, 1995, 86 (10) : 3881 - 3881
  • [10] Bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma: results of a phase I/II clinical trial
    Popat, R.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singeri, C.
    Gurnbleton, T.
    Foot, N.
    Oakervee, H.
    Cavenagh, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 60 - 61
12345